Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
0.7249
Dollar change
+0.0049
Percentage change
0.68
%
Index- P/E- EPS (ttm)-14.42 Insider Own25.72% Shs Outstand2.11M Perf Week-7.18%
Market Cap1.53M Forward P/E- EPS next Y-2.27 Insider Trans0.00% Shs Float1.57M Perf Month-75.16%
Income-16.89M PEG- EPS next Q-1.53 Inst Own0.10% Short Float0.51% Perf Quarter-78.67%
Sales0.00M P/S- EPS this Y56.21% Inst Trans-18.31% Short Ratio0.09 Perf Half Y-86.35%
Book/sh-1.04 P/B- EPS next Y60.04% ROA-156.21% Short Interest0.01M Perf Year-90.77%
Cash/sh0.89 P/C0.82 EPS next 5Y- ROE-241.52% 52W Range0.63 - 11.77 Perf YTD-77.35%
Dividend Est.- P/FCF- EPS past 5Y-20.69% ROI- 52W High-93.84% Beta1.25
Dividend TTM- Quick Ratio0.72 Sales past 5Y0.00% Gross Margin- 52W Low14.77% ATR (14)0.33
Dividend Ex-Date- Current Ratio0.72 EPS Y/Y TTM6.35% Oper. Margin0.00% RSI (14)26.27 Volatility11.62% 14.92%
Employees7 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price20.00
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q-111.83% Payout- Rel Volume0.54 Prev Close0.72
Sales Surprise- EPS Surprise- Sales Q/Q- EarningsMay 13 AMC Avg Volume92.32K Price0.72
SMA20-61.88% SMA50-76.09% SMA200-85.65% Trades Volume49,401 Change0.68%
May-15-24 01:55PM
08:36AM
08:20AM
08:14AM
08:00AM
07:29AM Loading…
07:29AM
May-13-24 10:53PM
04:10PM
Apr-30-24 07:30AM
Apr-24-24 02:52PM
Mar-26-24 07:30AM
Feb-27-24 07:31AM
07:30AM
Feb-07-24 07:30AM
Dec-29-23 07:30AM
07:10AM Loading…
Nov-17-23 07:10AM
07:00AM
Nov-15-23 04:15PM
Oct-31-23 08:58AM
Oct-12-23 08:02AM
Oct-02-23 08:58AM
Sep-27-23 08:58AM
Sep-26-23 08:58AM
Sep-22-23 11:27AM
Sep-21-23 10:00AM
Sep-18-23 07:58AM
Sep-05-23 09:00AM
Aug-28-23 08:58AM
Aug-14-23 09:00AM
Aug-10-23 08:58AM
07:00AM Loading…
Jul-24-23 07:00AM
Jul-13-23 08:58AM
Jun-21-23 08:00AM
Jun-20-23 04:10PM
Jun-13-23 08:58AM
May-12-23 04:08PM
May-10-23 07:15AM
May-09-23 07:15AM
May-04-23 08:58AM
May-02-23 03:30PM
Apr-27-23 08:58AM
Apr-05-23 08:58AM
Mar-28-23 08:58AM
Mar-22-23 08:58AM
Feb-13-23 08:58AM
Jan-31-23 08:58AM
Jan-18-23 09:00AM
Jan-10-23 09:00AM
Jan-04-23 09:00AM
Dec-14-22 09:00AM
Nov-09-22 09:00AM
Oct-13-22 06:29AM
Aug-24-22 09:00AM
Aug-15-22 09:00AM
Jul-22-22 11:32AM
Jul-05-22 09:00AM
Jul-01-22 04:04PM
06:33AM
Jun-30-22 06:44AM
04:00AM
Jun-29-22 04:06PM
11:30AM
09:32AM
Jun-28-22 07:08PM
05:01PM
04:37PM
11:14AM
Jun-27-22 12:13PM
09:00AM
Jun-24-22 12:25PM
Jun-23-22 04:34PM
04:00AM
May-19-22 09:00AM
May-16-22 09:00AM
May-06-22 06:12AM
May-05-22 09:00AM
Apr-26-22 09:00AM
Mar-31-22 09:00AM
Mar-22-22 09:00AM
04:00AM
Mar-15-22 01:45PM
10:06AM
09:00AM
Feb-15-22 09:00AM
Feb-10-22 09:00AM
Jan-21-22 11:00AM
Jan-18-22 09:00AM
Jan-04-22 09:20AM
Dec-28-21 08:00AM
Dec-20-21 08:00AM
Dec-08-21 08:00AM
Dec-01-21 07:16AM
Nov-27-21 08:04AM
Nov-15-21 08:00AM
Nov-10-21 08:00AM
Oct-20-21 07:00AM
Oct-06-21 09:00AM
Oct-01-21 08:00AM
Sep-20-21 09:00AM
Sep-16-21 01:00PM
Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.